| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |